Host-pathogen interactions represent a dynamic interplay between a host organism and a pathogenic microorganism. At the molecular level, pathogens employ various strategies to invade host tissues, evade immune detection, and replicate. Host cells, in turn, deploy an intricate array of defense mechanisms to recognize, neutralize, and eliminate invading pathogens. Recognition of pathogens by the host's innate immune system is often mediated by pattern recognition receptors (PRRs) that detect conserved microbial structures known as pathogen-associated molecular patterns (PAMPs). This recognition triggers signaling cascades leading to the activation of immune responses, including the release of cytokines, chemokines, and the recruitment of immune cells. Adaptive immunity, involving T and B lymphocytes, plays a crucial role in specific pathogen recognition and long-term immunity. T cells recognize antigens presented by infected cells, triggering an immune response tailored to the specific pathogen. B cells produce antibodies that neutralize pathogens and mark them for destruction by other immune cells. Pathogens, on the other hand, have evolved numerous strategies to evade host immune defenses. These include the modulation of host cell signaling, antigenic variation, and interference with immune cell functions. Some pathogens can even subvert host immune responses to establish persistent infections.Understanding the molecular intricacies of host-pathogen interactions provides insights into disease pathogenesis and guides the development of therapeutic strategies. Research in this field continues to uncover new facets of the complex relationship between hosts and pathogens, informing the design of vaccines, antiviral drugs, and immunotherapies.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain